Scientific Presentations

Comprehensive Analysis of the Editing Window of TALE Base Editors - Keystone Symposia “Precision Genome Engineering” - Poster Presentation

Download the PDF file

TALEN®-edited Allogeneic Inducible Dual CAR T-cells Enable Effective Targeting of Solid Tumors - Keystone Symposia “Emerging Cellular Therapies” - Poster Presentation

Download the PDF file

Preclinical efficacy of PD-L1/TGF-beta resistant MUC1-CAR T-cells with inducible IL12 against triple-negative breast cancer - Keystone Symposia “Emerging Cellular Therapies” - Poster Presentation

Download the PDF file

Updated Results of the Phase I BALLI-01 Trial of UCART22 Process 2 (P2), an Anti-CD22 Allogeneic CAR-T-Cell Product Manufactured by Cellectis Biologics, in Patients with Relapsed or Refractory (R/R) CD22+ (B-ALL) - ASH 2023 - Poster Presentation

Download the PDF file

Preliminary Results of NatHaLi-01: A First-In-Human Phase I/IIa Study of UCART20x22, a Dual Allogeneic CAR-T Cell Product Targeting CD20 and CD22, in Relapsed or Refractory (R/R) Non-Hodgkin Lymphoma (NHL) - ASH 2023 - Poster Presentation

Download the PDF file

TGFBR2 KO combined with activation-induced IL12 secretion synergize to optimize potency and safety of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer - SITC 2023 - Poster Presentation

Download the PDF file

Comprehensive Analysis of the Editing Window of TALE Base Editors - ESGCT 2023 - Poster Presentation

Download the PDF file

Intronic editing enables lineage-specific expression of therapeutics relevant for HSPC gene therapy - ESGCT 2023 - Poster presentation

Download the PDF file

Non-Viral DNA Delivery Coupled To TALEN Gene Editing Efficiently Correct The Sickle Cell Mutation In Long-Term HSCS - ESGCT 2023 - Poster Presentation

Download the PDF file

TALEN®-Edited Inducible Dual Car T-Cells Aimed at Safe and Effective Targeting Of Solid Tumors - CICON 2023 - Poster Presentation

Download the PDF file